Loading publications…
The last 5 uploaded publications
Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial
Manel Sabaté, Stephan Windecker, Andrés Íñiguez, Lisette Okkels Jensen, Ángel Cequier, Salvatore Brugaletta, Sjoerd H. Hofma, Lorenz Räber, Evald Høj Christiansen, Maarten J. Suttorp, Thomas Pilgrim, Gerrit Anne van Es, Yohei Sotomi, Héctor M. García‐García, Yoshinobu Onuma, Patrick W. Serruys (2015). Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial. European Heart Journal, 37(3), pp. 229-240, DOI: 10.1093/eurheartj/ehv500.
Article146 days agoRelationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving System—A Bern-Rotterdam Study
Nicolò Piazza, Peter Wenaweser, Menno van Gameren, Thomas Pilgrim, Apostolos Tsikas, Amber Otten, Rutger Nuis, Yoshinobu Onuma, Jin Cheng, A. Pieter Kappetein, Eric Boersma, Peter Jüni, Peter de Jaegere, Stephan Windecker, Patrick W. Serruys (2010). Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving System—A Bern-Rotterdam Study. American Heart Journal, 159(2), pp. 323-329, DOI: 10.1016/j.ahj.2009.11.026.
Article146 days agoImpact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity
Konstantinos C. Koskinas, George C.M. Siontis, Raffaele Piccolo, Anna Franzone, Alan G. Haynes, Julie Rat-Wirtzler, Sigmund Silber, Patrick W. Serruys, Thomas Pilgrim, Lorenz Räber, Dik Heg, Peter Jüni, Stephan Windecker (2016). Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity. Circulation Cardiovascular Interventions, 9(2), DOI: 10.1161/circinterventions.115.003255.
Article146 days agoRisk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non–ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction
Thomas Pilgrim, Pascal Vranckx, Marco Valgimigli, Giulio Stefanini, Raffaele Piccolo, Julie Rat, Martina Rothenbühler, Stefan Stortecky, Lorenz Räber, Stefan Blöchlinger, Lukas Hunziker, Sigmund Silber, Peter Jüni, Patrick W. Serruys, Stephan Windecker (2016). Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non–ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction. American Heart Journal, 175, pp. 56-65, DOI: 10.1016/j.ahj.2016.01.021.
Article146 days agoImpact of Sex on Clinical and Angiographic Outcomes Among Patients Undergoing Revascularization With Drug-Eluting Stents
Giulio Stefanini, Bindu Kalesan, Thomas Pilgrim, Lorenz Räber, Yoshinobu Onuma, Sigmund Silber, Patrick W. Serruys, Bernhard Meier, Peter Jüni, Stephan Windecker (2012). Impact of Sex on Clinical and Angiographic Outcomes Among Patients Undergoing Revascularization With Drug-Eluting Stents. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 5(3), pp. 301-310, DOI: 10.1016/j.jcin.2011.11.011.
Article146 days ago